About: A Two-Year Observational Follow-up Study of Subjects With Major Depressive Disorder Following a Randomized, Double-Blind Single-Dose of Psilocybin or Niacin-Control

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: A Two-Year Observational Follow-up Study of Subjects With Major Depressive Disorder Following a Randomized, Double-Blind Single-Dose of Psilocybin or Niacin-Control Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

clinical trial

Attributes	Values
rdf:type	Item
description	clinical trial (en) ensayo clínico (es) ensayu clínicu (ast) klinisch onderzoek (nl) клінічне випробування (uk)
rdfs:label	A Two-Year Observational Follow-up Study of Subjects With Major Depressive Disorder Following a Randomized, Double-Blind Single-Dose of Psilocybin or Niacin-Control (en) A Two-Year Observational Follow-up Study of Subjects With Major Depressive Disorder Following a Randomized, Double-Blind Single-Dose of Psilocybin or Niacin-Control (nl)
skos:prefLabel	A Two-Year Observational Follow-up Study of Subjects With Major Depressive Disorder Following a Randomized, Double-Blind Single-Dose of Psilocybin or Niacin-Control (en) A Two-Year Observational Follow-up Study of Subjects With Major Depressive Disorder Following a Randomized, Double-Blind Single-Dose of Psilocybin or Niacin-Control (nl)
name	A Two-Year Observational Follow-up Study of Subjects With Major Depressive Disorder Following a Randomized, Double-Blind Single-Dose of Psilocybin or Niacin-Control (en) A Two-Year Observational Follow-up Study of Subjects With Major Depressive Disorder Following a Randomized, Double-Blind Single-Dose of Psilocybin or Niacin-Control (nl)
title	wds:Q92272899-E1F0A6F2-ADB6-431B-9C3B-C3ACC4852ADF
title	A Two-Year Observational Follow-up Study of Subjects With Major Depressive Disorder Following a Randomized, Double-Blind Single-Dose of Psilocybin or Niacin-Control (en)
end time	wds:Q92272899-014AF29E-E014-496D-BB7E-BBD425446BB7
end time	2022-10-01 00:00:00Z (xsd:dateTime)
instance of	wds:Q92272899-9D4C1C0E-9275-44C1-AB49-7E841FB7F366
instance of	clinical trial
start time	wds:Q92272899-BB3B41CE-D76F-46D3-8BB9-FEDB7947538A
start time	2020-04-01 00:00:00Z (xsd:dateTime)
country	wds:Q92272899-705533E8-E471-4F86-8427-1FCF37C37CD7
country	United States of America
minimum age	wds:Q92272899-B08FB092-5150-4395-A25F-1F277FDA9157
minimum age	21 (xsd:decimal)
number of participants	wds:Q92272899-7DA3EAE8-0C73-4578-945E-3F26823EC1A7
number of participants	80 (xsd:decimal)
maximum age	wds:Q92272899-3169656D-CFF7-4C4B-8979-11EC2754887C
maximum age	65 (xsd:decimal)
study type	wds:Q92272899-AAD5DE22-0602-4CF7-B219-DB48A883F73E
study type	observational study
ClinicalTrials.gov ID	wds:Q92272899-DC9095A7-0030-47EB-A02D-B91053C81598
ClinicalTrials.gov ID	NCT04353921
research subject recruitment status	wds:Q92272899-14269B99-2213-4FDD-8D23-FA82D7DCBD57
research subject recruitment status	enrolling by invitation
is owl:sameAs of	A Two-Year Observational Follow-up Study of Subjects With Major Depressive Disorder Following a Randomized, Double-Blind Single-Dose of Psilocybin or Niacin-Control
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q92272899

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 190 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software